Because there are no BC cellular models available with a knockout for CASD1, the modulation of CASD1 expression was adopted as the strategy to assess the potential SOAT activity of CASD1 on GD2 O-acetylation in SUM159PT BC cell line. The gene discussed is CASD1; the disease is breast cancer.